CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Climara

estradiol· ingredient estradiol· ESTRADIOL .025 mg/d; ESTRADIOL .0375 mg/d; ESTRADIOL .05 mg/d; ESTRADIOL .06 mg/d
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$12.45
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other estradiol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Estradiol$0.06599−$12.38
Estradiol$0.06599−$12.38
ESTRACE$0.38605−$12.06
ABIGALE$0.69593−$11.75
Mimvey$0.70126−$11.75
DIVIGEL$1.47−$10.97
ELESTRIN$3.52−$8.93
DOTTI$7.65−$4.80

Medicare Part D coverage · CY2026

On 317 plan formularies · typical tier 3
Prior auth 2% · Step therapy 0% · Quantity limit 54% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.